Central Pharmaceuticals (DHA:CENTRALPHL) Other Net Income (Loss) : BDT0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Central Pharmaceuticals Other Net Income (Loss)?

Central Pharmaceuticals's Other Net Income (Loss) for the three months ended in Mar. 2024 was BDT0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was BDT0.0 Mil.

Central Pharmaceuticals's quarterly Other Net Income (Loss) declined from Sep. 2023 (BDT0.0 Mil) to Dec. 2023 (BDT0.0 Mil) but then increased from Dec. 2023 (BDT0.0 Mil) to Mar. 2024 (BDT0.0 Mil).

Central Pharmaceuticals's annual Other Net Income (Loss) increased from Jun. 2021 (BDT-0.0 Mil) to Jun. 2022 (BDT0.0 Mil) but then stayed the same from Jun. 2022 (BDT0.0 Mil) to Jun. 2023 (BDT0.0 Mil).

Central Pharmaceuticals Other Net Income (Loss) Historical Data

The historical data trend for Central Pharmaceuticals's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Central Pharmaceuticals Other Net Income (Loss) Chart

Central Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Net Income (Loss)

Get a 7-Day Free Trial

Central Pharmaceuticals Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Central Pharmaceuticals Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0.0 Mil.

Central Pharmaceuticals Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Central Pharmaceuticals's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Central Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceuticals Ltd (DHA:CENTRALPHL) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

South West Darus Salam Road, 2-A/1, 2nd Floor, Mirpur - 1, Dhaka, BGD, 1216

Website

https://www.centralphl.com

Central Pharmaceuticals Ltd is engaged in the manufacturing and marketing of medicines in Bangladesh. The company manufactures finished formulation products for general people, hospitals, clinics, government organizations, corporations, and other non-government organizations. Its product portfolio encompasses therapeutic categories including gastrointestinal, anti-infective, vitamins and minerals, allergy cough and cold, analgesic and musculoskeletal, dermatological, oral rehydration salt, and others. The products are in the dosage forms of tablets, capsules, liquid, and ointments.

Central Pharmaceuticals Headlines

No Headlines